Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Local Meeting Held In California To Discuss HIV/AIDS Spending Priorities In Face Of Proposed State Budget Cuts
The Inland Empire HIV Planning Council, an agency that makes HIV/AIDS policy in Riverside and San Bernardino counties in California, has begun a three-day summit, where they will determine how funds - primarily from HHS - will be spent, the Riverside Press-Enterprise reports. The council, which oversees spending of more than $7 million for HIV/AIDS care and treatment in the counties, said proposed cuts to HIV/AIDS programs and Medi-Cal at the state level "could affect funding and treatment priorities set by the agency," the article states. Joe Acosta, co-chair of the council said they are looking for ways to make up for the expected shortfalls. The council distributes money to about a half dozen agencies in San Bernardino and Riverside counties that provide services to more than 6,800 HIV/AIDS patients, Acosta said" (Hines, 7/18).
generic viagra online
Blood-Pressure Drug Shrinks Scars In The Livers Hepatitis C Sufferers
A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients.
News of the day
Turner Syndrome Society Of The United States Announces Ambitious Goal To Crush Ignorance Of Turner Syndrome (TS)
The Turner Syndrome Society of the United States (TSSUS) recently concluded its 22nd Annual Conference in Portland, Oregon. The conference drew more than 350 individuals, families, researchers and health care professionals to network and learn about the latest research breakthroughs benefiting women and girls with TS.
Medical Devices

Baxter To Acquire Continuous Renal Replacement Therapy Business From Edwards Lifesciences

Baxter International Inc. (NYSE:BAX) announced today a definitive agreement with Edwards Lifesciences Corporation (NYSE:EW) under which Baxter will acquire certain assets related to Edwards" hemofiltration product line, also known as Continuous Renal Replacement Therapy (CRRT). The transaction is expected to close in the third quarter of 2009, pending regulatory approvals. Under the terms of the agreement, Baxter will provide Edwards an initial cash payment of approximately $56 million upon the close of the transaction. Additionally, Baxter will receive transition services from Edwards and is expected to pay Edwards up to an additional $9 million based on revenue objectives expected to be achieved over the next two years. The impact of this transaction is immaterial to Baxter"s financial results for 2009. Hemofiltration, or CRRT, mimics the function of the kidneys 24 hours a day for patients with life-threatening kidney injuries or edema (fluid overload). CRRT provides a method of continuous yet adjustable fluid removal that can gradually remove excess fluid and waste products that build up with the acute impairment of kidney function, and is usually administered in an intensive care setting in the hospital. Baxter currently supplies solutions used in CRRT treatment globally, and is the exclusive distributor of Edwards" product in China, Latin America and the United States. Approximately 60 employees will be joining Baxter from Edwards as part of this transaction. "As an experienced leader in dialysis therapies including CRRT, this acquisition represents an extension of our existing Renal business, and demonstrates our commitment to save and sustain the lives of patients with acute kidney injuries," said Bruce McGillivray, corporate vice president and president of Baxter"s Renal business. "This acquisition expands Baxter"s existing CRRT business, which is predominantly in the United States and China, into new markets such as Europe and Australia." Baxter International Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009